TN Starr, N Czudnochowski, Z Liu, F Zatta, YJ Park… - Nature (London), 2021 - osti.gov
An ideal therapeutic anti-SARS-CoV-2 antibody would resist viral escape1, 2, 3, have
activity against diverse sarbecoviruses4, 5, 6, 7, and be highly protective through viral …